Spinogenix, the company behind the once-a-day pill that restored lost nerve cell connections in people with amyotrophic ...

Mayo Clinic researchers have just been awarded a new federal grant to start an investigation of an experimental drug on ...

In a first-of-a-kind collaboration, Target ALS, a foundation breaking down barriers to amyotrophic lateral sclerosis (ALS) ...

This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...

A New Bedford man, Joseph Smith, admitted to stealing over $450,000 in disability benefits from a veteran with ALS and ...

Over a decade of clinical data, experience and know-how with lead polyclonal Treg cell therapy PTG-007 in type-1 diabetes will accelerate ...

Mayo Clinic researchers have just been awarded a new federal grant to start an investigation of an experimental drug on ...

Two specific conditions are exempt from the 24-month waiting period: end-stage kidney disease and amyotrophic lateral sclerosis (ALS). Individuals with these diseases can qualify for Medicare no ...

A tailored cocktail of genes can reprogram a subset of progenitors to no longer produce glial cells and instead develop into neurons involved in motor control.

Founded in 2009, the Luxembourg Centre for Systems Biomedicine (LCSB) is celebrating 15 years of contribution to biomedical research in Luxembourg and beyond. Focusing on neurodegenerative disorders ...

A sneak peek at upcoming street fairs, festivals, concerts, performances, art shows, blood drives, community meetings and ...

Sudden uncontrollable and inappropriate laughing or crying is a symptom of pseudobulbar affect (PBA), a neurological ...